Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by...
-
Upload
charles-clarke -
Category
Documents
-
view
217 -
download
0
Transcript of Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by...
![Page 1: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/1.jpg)
Management of Aniridic Management of Aniridic Keratopathy with Keratopathy with Allograft Limbal Stem Allograft Limbal Stem Cell Transplantation Cell Transplantation Followed by Followed by PhacoemulsificationPhacoemulsification SurgerySurgery
Sibel Aksoy, MD, Yonca A. Akova, MD Baskent University, School of Medicine Department of Ophthalmology Ankara-Turkey
The authors acknowledge no financial interest in the subject matter of this
presentation
![Page 2: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/2.jpg)
PurposePurpose
To report a case of aniridic keratopathy treated with allograft limbal stem cell transplantation (ALSCT) and medical theraphy including bevacizumab followed by phacoemulsification surgery for congenital cataract
![Page 3: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/3.jpg)
CaseCase29 years-old female Presented to our clinic with blurred
vision and photophobia in both eyesVisual acuities were 20/60 in the
right eye and counting fingers at 1 meter in the left eye
Intraocular pressures were normal OD: Normal fundus findings
OS : Fundoscopic examination was not possible
![Page 4: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/4.jpg)
Anterior Segment Anterior Segment ExaminationExaminationEpithelial defects
and cloudy cornea in the left eye
Paracentral and 3600 peripheral corneal neovascularization in the left eye
Bilateral aniridia Bilateral congenital
lamellar cataract
OD
OS
![Page 5: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/5.jpg)
Left eye treated with superficial keratectomy, allogreft limbal stem cell transplantation and amniotic membrane transplantation
Topical lomefloxacin (4x1), topical dexamethasone (8x1), topical hydroxypropylmethilcellulose(8x1), oral cyclosporine A (3mg/kg) and oral metilprednisolone (0,5mg/kg)
Decreased gradually
SURGICAL TREATMENT MEDICAL TREATMENT
![Page 6: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/6.jpg)
The day after surgery
Figures showing
amniotic
membrane
transplantation
and corneal
sutures of the
limbal graft at
superior temporal
and inferior nasal
quadrants
![Page 7: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/7.jpg)
• VA: Finger counting from 2 meters
• Obvious reduction in vascularity
• Increased epithelization
• Decreased haze
Pre-therapy
Post-therapy
Postoperative 6 months
![Page 8: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/8.jpg)
• Revascularization at the inferior and nasal quadrants
• Subconjunctival (0.04 mg/ 0.01ml) and topical bevacizumab (4x1) treatment were added
Postoperative1 year
![Page 9: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/9.jpg)
Follow-up reduction of vascularization
Phacoemulsifica
tion and
intraocular lens
implantation
was performed
1.5 years after
ALSCT
![Page 10: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/10.jpg)
Postoperative 6 Postoperative 6 monthsmonthsVisual acuity
increased to 20/200
Corneal epithelium was intact with minimal surface vascularity
No side effects of bevacizumab treatment were seen
![Page 11: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/11.jpg)
ConclusionConclusionAniridia is a congenital, almost
always bilateral, pan-ocular and non-self limiting disease
ALSCT as well as systemic immunosuppression and bevacizumab therapy improved the aniridic keratopathy in our patient
It is a progressive disease and long term follow-up is needed
![Page 12: Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,](https://reader030.fdocuments.net/reader030/viewer/2022032414/56649ef05503460f94c009ba/html5/thumbnails/12.jpg)
NAME: Sibel Aksoy, M.D.
TITLE: Resident in Ophthalmology
DATE AND PLACE OF BIRTH : November 20, 1979, Turkey
2002: Doctor of Medicine, Osmangazi University, School of Medicine, Eskisehir, Turkey
2004-2009: Resident, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey
NAME: Yonca Aydın Akova, M.D.
TITLE: Professor in Ophthalmology
DATE AND PLACE OF BIRTH: October 21, 1960, Turkey
1983: Doctor of Medicine, Istanbul University, School of Medicine
1990: Istanbul University, School of Medicine, Department of Ophthalmology
2000:Professor of Ophthalmology, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey
2002: Chairperson, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey